Two Year Safety And Clinical Performance Of The Drug Eluting Orsiro Stent In The Treatment Of Subjects With Single De Novo Coronary Artery Lesions (BIOFLOW-II) - Michael Haude, MD, PhD

↳ This is a section part of Moment: CRT 2015 - Best Abstracts II

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$10.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Preview

Summary

Two Year Safety And Clinical Performance Of The Drug Eluting Orsiro Stent In The Treatment Of Subjects With Single De Novo Coronary Artery Lesions (BIOFLOW-II) presented by Michael Haude, MD, PhD at CRT 2015

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$10.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Target Audience

  • Interventional Cardiologists
  • Interventional Fellows
  • Interventional Radiologists
  • Vascular Surgeons

Learning Objectives

  • Updates in the Best Abstracts to feature at CRT 2015

Other Components in this Moment

Overview
Two Year Safety And Clinical Performance Of The Drug Eluting Orsiro Stent In The Treatment Of Subjects With Single De Novo Coronary Artery Lesions (BIOFLOW-II) - Michael Haude, MD, PhD
Fibrous Cap Thickness of Large Lipid-rich Plaques Detected by Intracoronary Near-infrared Spectroscopy - Mohsin K Khan, MD
Anti-coagulant Therapy During Percutaneous Coronary Intervention: A Network Meta-analysis of Randomized Trials - Tilak Pasala, MD
Clinical Outcomes Of The BIOFLEX-I Study: Utilization Of Self Expanding Stents In The Iliac Arteries - Mark W Burket, MD
Long Term Safety And Efficacy Of Sympathetic Renal Artery Denervation Using A Multi-electrode Renal Artery Denervation Catheter In Patients With Drug-resistant Hypertension - Vasilios Papademetriou, MD, DSc
Bioflow-III An All Comers Registry With A Sirolimus Eluting Stent- One Year Safety And Performance Results - Johannes L Waltenberger, MD
Loading Simple Education